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Abstract 
The (βα)8-barrel fold is the most frequently observed topology among enzymes. Due to 
the spatial separation of their activity- and stability-mediating sites, (βα)8-barrel en-
zymes are extremely versatile and catalyze a wide array of cellular reactions. Thus, this 
particular fold provides an ideal tool for modifying catalytic activity and studying 
enzyme evolution. 
Several (βα)8-barrel enzymes are involved in the metabolism of amino acids. Along 
these lines, N’-[(5‘-phosphoribosyl)formimino]-5-aminoimidazole-4-carboxamide ribo-
nucleotide isomerase (HisA) and the cyclase subunit of imidazole glycerol phosphate 
synthase (HisF) catalyze two consecutive steps in the biosynthesis of histidine, namely 
a sugar isomerization and a cycloligase/lyase reaction. By analogy with HisA, the 
enzyme phosphoribosyl anthranilate isomerase (TrpF) performs a chemically equi-
valent isomerization reaction within the biosynthesis of tryptophan. As HisA, HisF, 
and TrpF accommodate their phosphorylated substrates via a common phosphate 
binding site, an evolutionary linkage seems to exist between these three (βα)8-barrel 
proteins. Consequently, HisA and HisF could be engineered to bind and process the 
TrpF substrate phosphoribosyl anthranilate (PRA). In both cases, a single aspartate-to-
valine substitution was sufficient to establish PRA isomerase activity and the 
combination with a second aspartate-to-valine exchange significantly improved the 
turnover number. Since HisA and TrpF operate through an identical acid-base 
mechanism, the same enzymatic mechanism could be expected for the PRA isomerase 
activities generated on the HisA and HisF scaffolds. However, while mutational 
analyses and docking studies revealed a respective general base, no appropriate 
general acid could be identified. Therefore, the mechanistic foundation of the artifi-
cially designed PRA isomerase activity was addressed in the first part of this work. 
Initially recorded pH dependences substantiated the mechanistic differences of the 
naturally occurring and the artificially designed PRA isomerase activity. While TrpF 
wild-type exhibited the expected bell-shaped pH profile, merely an acidic limb was 
observed for the investigated HisA variants, suggesting that the hitherto unidentified 
general acid is rate-limiting for the engineered reaction. A hint on the nature of the 
catalytic acid was subsequently obtained from the crystal structure of the HisF double 
mutant with a bound product analogue. The structure suggested that within the 
enzyme–substrate complex the anthranilic acid moiety of PRA might donate a proton 
to the furanose ring oxygen of its sugar moiety. This productive geometry of PRA was 
compared with a non-productive binding mode in molecular dynamics simulations of 
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the HisA variants. In contrast to HisA wild-type, all variants clearly favor an orienta-
tion of PRA required for catalysis. Furthermore, the introduced valine residues clearly 
upshift the pKa value of anthranilic acid to a catalytically useful range. Mixed quantum 
and molecular mechanics calculations of the HisA double mutant with bound PRA 
finally demonstrated that an internal proton transfer is also feasible from an energetic 
point of view and presumably proceeds via a bridging water molecule. In sum, the 
artificial PRA isomerase activity established on the HisA and HisF scaffolds appears to 
be partly based on substrate-assisted catalysis and thus mechanistically deviates from 
the PRA isomerase activity of TrpF. 
The second part of this dissertation dealt with the evolution of cellular complexity. 
Modern organisms are highly developed molecular machineries, which rely on elabo-
rate enzyme systems. There is considerable interest to figure out which degree of 
enzymatic sophistication had already been reached in the very early phases of 
biological evolution. Along these lines, substantial progress has been made in the field 
of ancestral sequence reconstruction, which links computational and evolutionary 
biology and enables the characterization of extinct proteins. In extreme cases, enzymes 
from the last universal ancestor of cellular organisms (LUCA) can be studied. The 
LUCA preceded the diversification into the three domains of life and existed at least 3.5 
billion years ago. 
Exceptional catalytic features like substrate channeling and allosteric communica-
tion are observed in the imidazole glycerol phosphate synthase bi-enzyme complex of 
the cyclase HisF and the glutaminase HisH. In an attempt to analyze its primal 
characteristics, we reconstructed a HisF enzyme from the LUCA era (LUCA-HisF). 
LUCA-HisF could be expressed solubly in Escherichia coli and purified with a high 
yield. The protein furthermore shows a high thermostability and a folding mechanism 
comparable to extant (βα)8-barrel enzymes. Accordingly, its subsequently solved 
crystal structure equals contemporary HisF proteins. Beyond its structural integrity, 
LUCA-HisF proved to be a highly active and specific enzyme. As its catalytic sophis-
tication could only be completely assessed in combination with an interacting gluta-
minase, we additionally reconstructed a respective LUCA-HisH sequence. Although 
both proteins form a stoichiometric complex with high affinity, no catalytic activity 
could be determined for LUCA-HisH, probably due to uncertainties in the reconstruct-
tion process. We instead turned to a complex between LUCA-HisF and the extant HisH 
enzyme from Zymomonas mobilis. Remarkably, LUCA-HisF could both stimulate the 
catalytic efficiency of the interacting glutaminase and transport the produced ammonia 
to its active site via a molecular channel. The evolution of these elaborate features 
therefore must already have been completed in the LUCA era. 
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The artificial control of enzymatic activity has been a long-standing goal in the 
field of protein design. Here, light provides an ideal trigger signal, since it enables a 
non-invasive and spatiotemporal regulation of biological activity. However, despite 
various attempts, only few enzymes have been successfully regulated by light so far. 
Therefore, the design of a light-controllable inhibitor of the (βα)8-barrel enzyme PriA 
from Mycobacterium tuberculosis (mtPriA) was the aim of the third section of this thesis. 
Interestingly, the bisubstrate-specific isomerase mtPriA is able to catalyze both the 
HisA and TrpF reaction and displays a potential target for anti-tuberculosis drugs, 
since humans can synthesize neither histidine nor tryptophan. 
For the construction of the potential inhibitors, two particular features of mtPriA 
could be harnessed, both of which originate from the molecular evolution from a (βα)4-
half-barrel precursor: the protein exhibits a striking twofold rotational symmetry as 
well as two opposite phosphate binding sites. Consequently, we chose the twofold 
symmetric, photoswitchable 1,2-dithienylethene (DTE) as a structural core and 
equipped it with terminal phosphate or phosphonate anchors. The synthesized DTE 
compounds could reversibly be toggled between a ring-open and ring-closed form by 
irradiation with UV and visible light, respectively. Both isomers were thermally stable, 
nearly quantitatively formed and robust over various switching cycles. When tested in 
steady-state enzyme kinetics, the open isomers of all DTE-phosphates and DTE-
phosphonates competitively inhibited the mtPriA activity with the inhibition constants 
lying in the low micromolar range. Notably, the inhibition activity was lowered up to a 
factor of eight upon ring-closure, where the enzymatic performance could be directly 
controlled during catalysis. The different binding affinities obtained upon irradiation 
seem to be based on a change in the conformational flexibility. Along these lines, 
molecular dynamics simulations of mtPriA with an inhibitor bound in both isomeric 
forms demonstrated that the ring-open isomers can readily adapt to the active site of 
mtPriA. In contrast, due to its restricted mobility, the interaction of the ring-closed 
form with the enzyme is energetically less favorable. Thus, the dual anchoring of 
photoswitchable inhibitors constitutes a viable design concept for the reversible 
regulation of enzymatic activity. The approach may additionally be transferred to other 
(βα)8-barrel proteins, as phosphate is a frequently encountered element of metabolic 
substrates. 
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Zusammenfassung 
Die (βα)8-Fass-Struktur ist der am häufigsten vorkommende Faltungstyp unter 
Enzymen. Durch die räumliche Separation von aktivitäts- und stabilitätsvermittelnden 
Aminosäuren, sind (βα)8-Fass-Enzyme extrem vielseitig und katalysieren ein breites 
Spektrum an zellulären Reaktionen. Deswegen stellt dieser besondere Faltungstyp ein 
ideales Gerüst zur Modifikation katalytischer Aktivität und zur Untersuchung 
enzymatischer Evolutionmechanismen dar. 
Gleich mehrere (βα)8-Fass-Enzyme sind am Aminosäuremetabolismus beteiligt. So 
katalysieren die N’-[(5‘-phosphoribosyl)formimino]-5-aminoimidazol-4-carboxamid 
ribonucleotid Isomerase (HisA) und die Zyklaseuntereinheit der Imidazolglycerin-
phosphat Synthase (HisF) zwei aufeinanderfolgende Schritte in der Histidinbiosyn-
these. HisA isomerisiert eine Ribosegruppe zu einer Aminoketose, die anschließend 
von HisF in einer Zykloligase/Lyase-Reaktion gespalten wird. Weiterhin existiert eine 
zur HisA-Reaktion äquivalente Zuckerisomerisierung innerhalb der Tryptophanbio-
synthese – das zuständige Enzym wird TrpF genannt. Die (βα)8-Fass-Proteine HisA, 
HisF und TrpF scheinen evolutionär verknüpft zu sein, da sie ihre phosphorylierten 
Substrate durch eine identische Phosphatbindestelle fixieren. So konnte die Umsetzung 
des TrpF-Substrates Phosphoribosylanthranilat (PRA) sowohl auf dem HisA- als auch 
auf dem HisF-Gerüst bereits durch den Austausch eines Aspartatrestes zu Valin 
etabliert werden. In beiden Fällen wurde die PRA-Isomerase-Aktivität durch Kombina-
tion mit dem Austausch eines weiteren Aspartatrestes zu Valin deutlich gesteigert. Da 
die HisA- und TrpF-Reaktion auf dem gleichen Säure-Base-Mechanismus beruhen, 
konnte ein identischer Reaktionsablauf auch für die auf HisA und HisF erzeugten 
PRA-Isomerisierungen erwartet werden. Obwohl Mutationsanalysen und Docking-
Ansätze zur Identifikation einer entsprechenden katalytischen Base führten, ergaben 
sich mit diesen Methoden jedoch keine Hinweise auf die allgemeine Säure. Deswegen 
wurden die mechanistischen Grundlagen der auf den HisA- und HisF-Grundgerüsten 
etablierten PRA-Isomerase-Aktivität im ersten Teil dieser Arbeit eingehender analy-
siert. 
Dazu wurden zunächst die pH-Abhängigkeiten der neu erzeugten und der 
natürlich vorkommenden PRA-Isomerase-Aktivität gemessen. Dabei zeigte der TrpF-
Wildtyp das erwartete glockenförmige pH-Profil, wohingegen bei den HisA-Varianten 
lediglich der Säureast beobachtet werden konnte. Die Varianten scheinen demnach 
einem Reaktionsmechanismus zu folgen, dessen Rate durch eine bis zu diesem 
Zeitpunkt unbekannte katalytische Säure limitiert wird. Welche Gruppe die Rolle der 
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allgemeinen Säure einnimmt, konnte anschließend mit Hilfe der Kristallstruktur einer 
HisF-Variante mit gebundenem Produktanalogon näher eingegrenzt werden. Diese 
Struktur legte den Schluss nahe, dass innerhalb des Enzym-Substrat-Komplexes der 
Anthranilsäureanteil von PRA ein Proton auf den Furanoseringsauerstoff des Zucker-
anteils übertragen könnte. Eine entsprechende Geometrie des Substrates PRA wurde 
daraufhin in Moleküldynamiksimulationen der HisA-Varianten mit einem unproduk-
tiven Bindungsmodus verglichen. Im Gegensatz zum HisA-Wildtyp, präferierten dabei 
alle Mutanten die katalytisch produktive Orientierung von PRA. Desweiteren 
verringern die eingeführten Valin-Reste die Acidität der Anthranilsäure und führen 
somit zu einer für die Katalyse notwendigen Erhöhung ihres pKa-Wertes. Schließlich 
zeigten kombinierte quantenmechanische/molekülmechanische Berechnungen der 
HisA-Doppelmutante mit gebundenem PRA, dass ein Protonentransfer innerhalb des 
Substrates auch energetisch möglich ist, wobei dafür vermutlich ein verbrückendes 
Wassermolekül benötigt wird. Zusammenfassend lässt sich sagen, dass die auf den 
HisA- und HisF-Grundgerüsten künstlich erzeugte PRA-Isomerase-Aktivität zum Teil 
auf Substrat-vermittelter Katalyse beruht und sich daher von der PRA-Isomerase-
Aktivität von TrpF unterscheidet. 
Der zweite Teil dieser Dissertation hatte die Evolution zellulärer Komplexität zum 
Thema. Während moderne Organismen bekanntlich auf ausgeklügelten Enzymsys-
temen basieren, existieren fast ausschließlich nur theoretische Arbeiten über die 
Komplexität der Spezies, die in einer sehr frühen Phase der Evolution auftraten. Jedoch 
wurde durch die kürzlich etablierte Rekonstruktion von Vorläufersequenzen eine 
Verknüpfung zwischen Bioinformatik und Evolutionsbiologie geschaffen. Mit Hilfe 
dieser Technik können die Sequenzen nicht mehr existierender Enzyme abgeleitet und 
damit ihre Eigenschaften charakterisiert werden. Im Extremfall lassen sich so Enzyme 
des letzten gemeinsamen Vorfahren aller zellulären Organismen (LUCA), aus dem sich 
vor etwa 3,5 Milliarden Jahren die heutigen Domänen des Lebens entwickelten, 
untersuchen. 
Der Imidazolglycerinphosphat-Synthase-Komplex aus der Zyklase HisF und der 
Glutaminase HisH zeichnet sich durch bemerkenswerte katalytische Eigenschaften 
aus. So wird bei Bindung des Liganden an HisF die Glutaminase-Aktivität allosterisch 
aktiviert und der gebildete Ammoniak durch einen Kanal zum aktiven Zentrum von 
HisF transportiert. Um die ursprünglichen Eigenschaften der komplexen Synthase 
HisF zu charakterisieren, wurde ein HisF-Enzym aus dem LUCA-Zeitalter rekon-
struiert (LUCA-HisF). Das Protein konnte löslich in Escherichia coli exprimiert und in 
hohen Ausbeuten gereinigt werden. LUCA-HisF zeigt eine hohe Thermostabilität und 
sowohl seine Kristallstruktur als auch sein Faltungsmechanismus gleichen rezenten 
HisF-Proteinen. Darüber hinaus zeigten in vivo-Studien und in vitro-Messungen, dass 
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LUCA-HisF ein hochaktives und spezifisches Enzym ist. Da seine katalytische 
Komplexität jedoch nur im Zusammenspiel mit einer interagierenden Glutaminase 
vollständig analysiert werden konnte, wurde zusätzlich die Sequenz eines ent-
sprechenden LUCA-HisH-Proteins abgeleitet. Obwohl beide Proteine einen stöchio-
metrischen und hoch-affinen Komplex ausbilden, erwies sich LUCA-HisH als 
katalytisch inaktiv, was vermutlich auf einen fehlerbehafteten Rekonstruktionsprozess 
zurückzuführen ist. Deshalb wurde stattdessen ein Komplex zwischen LUCA-HisF 
und dem rezenten HisH-Enzym aus Zymomonas mobilis untersucht. Tatsächlich führt 
die Ligandenbindung an LUCA-HisF zu einer erheblichen Steigerung der Gluta-
minase-Aktivität, wobei der dadurch erzeugte Ammoniak durch den verbindenden 
Kanal zum aktiven Zentrum von HisF gelangen kann. Die Evolution dieser komplexen 
Eigenschaften muss deswegen bereits vor circa 3,5 Milliarden Jahren abgeschlossen 
gewesen sein. 
Die artifizielle Regulation enzymatischer Aktivität ist ein seit Langem bestehendes 
Ziel auf dem Gebiet des Proteindesigns. Die Steuerung durch Licht ist besonders 
attraktiv, da sie eine nicht-invasive, räumliche und zeitliche Kontrolle biologischer 
Aktivität ermöglicht. Trotz zahlreicher Ansätze konnten jedoch bislang nur wenige 
Enzyme effizient durch Licht reguliert werden. Deswegen wurde im dritten Abschnitt 
dieser Arbeit ein lichtsteuerbarer Inhibitor des (βα)8-Fass-Enzyms PriA aus Myco-
bacterium tuberculosis (mtPriA) designt. Die Isomerase mtPriA katalysiert sowohl die 
HisA- als auch die TrpF-Reaktion und stellt ein potentielles Zielprotein für die 
Entwicklung von Antituberkulotika dar, weil Menschen weder Histidin noch Trypto-
phan herstellen können. 
Zwei besondere Strukturmerkmale konnten für das Design potentieller mtPriA-
Inhibitoren genutzt werden: Aufgrund seiner Evolution aus einem (βα)4-Halbfass-
Vorläufer, verfügt mtPriA über eine auffällige zweifache Rotationssymmetrie sowie 
über zwei gegenüberliegende Phosphatbindestellen. Dementsprechend wurde das 
zweifach rotationssymmetrische, lichtschaltbare Molekül 1,2-Dithienylethen (DTE) als 
strukturelles Gerüst der möglichen Inhibitoren verwendet und mit terminalen 
Phosphat- bzw. Phosphonat-Ankern versehen. Die synthetisierten DTE-Verbindungen 
konnten durch Bestrahlung mit UV- bzw. sichtbarem Licht reversibel zwischen einem 
offenen und einem geschlossenem Isomer hin- und hergeschaltet werden. Dieser 
Zyklus konnte mehrfach wiederholt werden, wobei beide Formen mit hohen Ausbeu-
ten gebildet wurden und thermisch stabil waren. Die Verbindungen wurden anschlie-
ßend in steady-state-Enzymkinetiken charakterisiert. Dabei zeigte sich, dass die offenen 
Formen aller DTE-Phosphate und -Phosphonate die mtPriA-Aktivität kompetitiv 
hemmen. Aus den erhaltenen Daten konnten Inhibitionskonstanten im niedrigen 
mikromolaren Bereich abgeleitet werden. Bemerkenswerterweise zeigten die geschlos-
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senen DTE-Formen bis zu achtfach reduzierte Inhibitionsaktivitäten. Dadurch konnte 
die enzymatische Umsatzgeschwindigkeit durch Bestrahlung mit UV-Licht unmittel-
bar während der Katalyse beeinflusst werden. Die ungleichen Bindungsaffinitäten der 
offenen und geschlossenen Formen basieren vorwiegend auf Unterschieden in der 
konformationellen Flexibilität. Dementsprechend zeigten Moleküldynamiksimulatio-
nen von mtPriA mit gebundenem Inhibitor, dass die offene Form sich ohne Weiteres an 
das aktive Zentrum anpassen kann. Im Gegensatz dazu ist das geschlossene Isomer 
erheblich in seiner Beweglichkeit eingeschränkt, was zu einer energetisch ungünsti-
geren Interaktion mit der enzymatischen Bindetasche führt. Die doppelte Verankerung 
von lichtschaltbaren Inhibitoren scheint daher ein erfolgreiches Designkonzept zur 
reversiblen Steuerung enzymatischer Aktivität darzustellen. Der hier beschriebene 
Ansatz kann im Prinzip auch auf weitere (βα)8-Fass-Enzyme übertragen werden, da 
Phosphat ein weit verbreiteter Baustein metabolischer Substrate ist. 
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1 General Introduction 
1.1 The (βα)
8
-barrel: one fold with diverse functions 
Enzymes are exceptional catalysts which facilitate a vast array of reactions under mild 
conditions [1]. In the absence of enzymes, vital reactions would last up to several 
million years [2] and thus by far exceed the life-span of living organisms [3]. The 
decarboxylation of orotidine 5`-phosphate, for example, proceeds with a half-time of 78 
million years in neutral solution. However, in the presence of orotidine 5`-phosphate 
decarboxylase from Saccharomyces cerevisiae the reaction is accelerated by a factor of 
1017, yielding a half-time of merely 18 milliseconds [4]. The catalytic efficiencies of most 
enzymes lie within a similar range as they are perfectly adapted to the conditions 
present in cells [2, 5]. Furthermore, in order to avoid side products, enzymes perform 
with high specificity and excellent chemo-, regio- and stereoselectivities [6].  
Except for a relative small number of catalytic RNAs, all enzymes are proteins [1]. 
The amino acid chain of each protein folds into a distinct three-dimensional topology 
which determines its stability and function. Surprisingly, although more than 41 
million protein sequences are known (UniProtKB/TrEMBL, release August 2013,  [7]), 
solely 1195 different folds have been observed to date (SCOP database, version 1.75, 
[8]). It has further been estimated that only around 2000 folds exist among naturally 
occurring proteins, some of which are more likely and hence more frequently 
encountered than others [9]. 
The most common fold among enzymes is the (βα)8- or TIM-barrel fold: it is 
observed in about 10 % of all structurally characterized proteins [10]. Besides the P-
loop-containing nucleoside triphosphate hydrolase fold and the DNA/RNA-binding 
three-helical bundle fold, the (βα)8-barrel fold belongs to the most ancient protein 
architectures [11]. Along these lines, (βα)8-barrel enzymes are mainly involved in basic 
biological processes like molecular or energy metabolism [12]. Herein, they catalyze 
more than 60 distinct reactions and accordingly cover all enzyme classes as defined by 
the Enzyme Commission [13], except for ligases [12]. 
The catalytic versatility of the (βα)8-barrel fold is based on its unique structural 
assembly [10]. The canonical (βα)8-barrel is composed of eight modular (βα)-units 
which are intrinsically linked via βα-loops, whereas the individual modules are 
connected by αβ-loops (Figure 1A). In the resulting tertiary structure, the β-strands 
form a central β-barrel, which is surrounded by the amphiphilic α-helices (Figure 1B). 
Their hydrophobic residues interact with the β-strands, while the opposite, hydrophilic 
side is exposed to the solvent.  
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Figure 1. The (βα)8-barrel fold. 
A: Schematic depiction of the right-handed (βα)-super-secondary structure. B: Side view of the 
fold`s three-dimensional structure in ribbon representation. The barrel is separated in a catalytic 
and a stability face. The figure was modified from [10]. β-strands and α-helices are depicted in 
blue and red, respectively; the connecting loops are shown in grey. 
In all known (βα)8-barrel enzymes, amino acids important for catalysis are located 
at the C-terminal ends of the β-strands and in the βα-loops (activity face). In contrast, 
the remainder of the fold, including the shorter αβ-loops, mediates the overall stability 
(stability face). As a consequence, the catalytic activity can in principle be modified 
without compromising stability, which renders the fold an ideal scaffold for studying 
natural enzyme evolution and designing novel catalytic activities [10, 14]. Thus, the 
swapping of βα-loops led to altered substrate specificities [15, 16], the introduction of 
few mutations enabled the catalysis of mechanistically similar reactions on either 
monofunctional [17] or promiscuous scaffolds [18-20] and even fairly unrelated 
reactions could be established [21, 22]. In addition, rational de novo enzyme design 
favored this particular fold over others, likely because catalytic and substrate-binding 
residues could easily be positioned in accordance with the desired transition state [23-
25]. 
1.2 Analyzed (βα)
8
-barrel enzymes 
The (βα)8-barrel fold is rather determined by the overall distribution of nonpolar, polar 
and charged residues than by details in the amino acid sequence [10]. Therefore, the 
sequence similarities of different (βα)8-barrel enzymes are generally low [26] with 
approximately 20 % identity at best [27, 28]. For this reason, it has been lively debated 
for more than two decades whether (βα)8-barrels result from convergent evolution to a 
stable protein fold or divergent evolution from a common ancestor [29, 30]. Even 
General Introduction 
 
13 
 
extensive comparisons of sequence, structure and function could not definitely rule out 
one of the two scenarios [12]. However, especially (βα)8-barrel enzymes involved in 
tryptophan and histidine biosynthesis share some striking features strongly suggesting 
an evolutionary connection. For example, phosphoribosylanthranilate (PRA) isomerase 
(TrpF), indole-3-glycerol phosphate synthase (TrpC), and the α-subunit of tryptophan 
synthase (TrpA), which catalyze three consecutive steps in tryptophan biosynthesis, 
anchor their mono-phosphorylated substrates via a common C-terminal phosphate 
binding site [28]. An analogous observation was made for two successive enzymes in 
histidine biosynthesis, namely N´-[(5´-phosphoribosyl)formimino]-5-aminoimidazole-
4-carboxamide ribonucleotide (ProFAR) isomerase (HisA) and imidazole glycerol 
phosphate (ImGP) synthase (HisF). In order to accommodate their bi-phosphorylated 
substrates, HisA and HisF utilize both the above mentioned C-terminal and an 
additional, N-terminal phosphate binding motif [31]. Furthermore, the entire folds of 
both enzymes exhibit a noticeable two-fold symmetry, which prompted their evolution 
from a (βα)4-half-barrel ancestor via gene duplication and fusion [32]. This process was 
successfully mimicked in the laboratory by constructing stable (βα)8-barrel proteins 
from different (βα)4-barrel modules. A well-defined tertiary structure was observed for 
the chimeric protein HisAF, consisting of the N-terminal (βα)1-4-units of HisA and the 
C-terminal (βα)5-8-units of HisF [33]. After fusing two copies of the C-terminal half of 
HisF, further optimization of the initial construct first led to a protein termed Sym1 and 
finally resulted in Sym2, whose stability even surpasses the one of the natural HisF 
template [33-35]. Most remarkably, few mutations were sufficient to establish 
enzymatic activity on both the HisAF and Sym2 scaffold, corroborating the postulated 
evolutionary pathway [36, 37]. 
Interestingly, TrpF and HisA catalyze chemically equivalent isomerization reac-
tions, even if their substrates significantly differ in size [38]. In a so-called Amadori 
rearrangement, the aminoaldoses PRA and ProFAR are converted to the corresponding 
ketoses 1-(2-carboxy-phenylamino)-1´-deoxyribulose-5´-phosphate (CdRP) and N´-[(5´-
phosphoribulosyl)formimino]-5-aminoimidazole-4-carboxamide ribonucleotide 
(PRFAR) (Figure 2). This linkage between the biosynthetic pathways of tryptophan and 
histidine is strengthened by the existence of a bisubstrate-specific isomerase PriA, 
which was found to catalyze both the isomerization of PRA and ProFAR in some 
Actinobacteria [39, 40]. 
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Figure 2. Reactions catalyzed by the (βα)8-barrel enzymes TrpF, HisA, PriA and HisF. 
TrpF (tryptophan biosynthesis) and HisA (histidine biosynthesis) catalyze the chemically analo-
gous Amadori rearrangements of the aminoaldoses PRA and ProFAR to the corresponding 
ketoses CdRP and PRFAR. The bifunctional enzyme PriA is able to catalyze both reactions. 
PRFAR is further metabolized to ImGP and AICAR by the ImGP synthase, which constitutes a 
bienzyme complex of the synthase HisF and the glutaminase HisH. While HisF performs the 
actual cycloligase/lyase reaction, HisH provides the required ammonia molecule via hydrolysis 
of glutamine (Gln) to glutamate (Glu). 
In comparison to the rather simple sugar isomerizations of TrpF and HisA, the 
reaction catalyzed by ImGP synthase is much more sophisticated. Belonging to the 
family of glutamine amidotransferases, ImGP synthase consists of a heterodimeric 
complex of the synthase HisF and the glutaminase HisH [41]. The latter hydrolyzes 
glutamine to glutamate and thereby produces ammonia, which is subsequently trans-
ported to the active site of HisF through an extended molecular channel [42, 43]. HisF 
then mediates the nucleophilic attack of the nascent ammonia molecule to PRFAR to 
yield ImGP and 5-aminoimidazole-4-carboxamide ribotide (AICAR) in a unique cyclo-
ligase/lyase reaction (Figure 2) [41]. Since AICAR is further used in de novo purine 
biosynthesis, ImGP synthase constitutes a branch-point enzyme in primary metabolism 
[44]. Most strikingly, the enzymatic activities of HisH and HisF are strictly coupled to 
prevent wasteful hydrolysis of glutamine: the glutaminase activity of HisH only 
reaches a significant level when the substrate PRFAR is bound to HisF [41, 44, 45]. The 
mechanism of this allosteric stimulation seems to be a complicated, delocalized process 
[46-48] and still has not been completely comprehended [49]. 
In the course of this work, the specified enzyme systems were investigated in three 
different projects. In the following, the respective objectives are introduced and the 
obtained results are presented and discussed in three separate sections.  
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2 Projects 
2.1 Project A: Mechanistic investigation of artificially generated 
PRA isomerase activity 
2.1.1 Introduction and objective 
The biosynthesis pathways of tryptophan and histidine share chemically equivalent 
sugar isomerization reactions, which are catalyzed by the enzymes TrpF and HisA 
(Figure 2). Consistently, both proteins operate via an identical acid-base mechanism 
[31, 50]. It therefore seemed plausible to interconvert the enzymatic activities of TrpF 
and HisA – an intention whose success would underpin their evolutionary relationship 
and the catalytic versatility of the underlying (βα)8-barrel fold [51]. Although both 
substrates contain a ribose-5-phosphate moiety, they significantly differ in size (Figure 
2). The HisA substrate ProFAR is equipped with a second ribose-5-phosphate group 
and thus exhibits about twice the molecular weight of the TrpF substrate PRA. Hence, 
HisA was chosen as a scaffold on which PRA isomerase (PRAI) activity should be 
established. This goal was accomplished by a combination of random mutagenesis and 
in vivo selection [51]. Under selective pressure, HisA even acquired low PRAI activity 
due to spontaneous mutations [52]. Furthermore, structurally related enzymes like 
HisF and TrpA could readily be modified in a way that they were able to process PRA 
to CdRP [53, 54] and few amino acid exchanges were sufficient to generate PRAI 
activity on the artificial and initially inert proteins HisAF and Sym2 [36, 37]. Most 
remarkably, glutamine phosphoribosylpyrophosphate amidotransferase (PurF), which 
is unrelated to TrpF in sequence, tertiary structure and catalytic mechanism, unexpect-
edly showed promiscuous and evolvable PRAI activity [21]. 
As the active sites of HisA and HisF closely match each other in terms of sequence 
and structure [32], it is not surprising that analogous mutations were found to establish 
PRAI activity on HisA and HisF from Thermotoga maritima and on their chimera HisAF. 
Notably, the introduction of a single equivalent amino acid exchange at the C-terminal 
end of β-strand 5 gave rise to a weak turnover of PRA to CdRP in all three cases 
(D127V in HisA and HisAF, D130V in HisF) [51, 54]. It has been suggested that the 
removal of the aspartate side chains abolishes electrostatic repulsion with the 
negatively charged anthranilate moiety of PRA [36, 54]. A similar mechanism was 
observed for the bisubstrate-specific isomerase PriA, which effectively shields the 
respective aspartate residue from PRA by insertion of a positively charged arginine 
side chain [50]. Along these lines, the introduction of another aspartate-to-valine 
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mutation in βα-loops 6 (D169V in HisA, D176V in HisF and D173V in HisAF) also was 
sufficient to gain moderate PRAI activity, at least on the HisA and HisAF scaffold [36]. 
Most strikingly, the combination of both substitutions significantly enhanced the 
catalytic efficiencies of all three enzymes. Acting synergistically, D127V+D169V (HisA), 
D130V+D176V (HisAF) and D127V+D173V (HisF) increased the kcat/  
  A values 16-, 
28- and 247-fold compared to the sum of the kcat/  
  A values of the single mutants 
(Table 1, publication A) [36]. While the resulting catalytic efficiency is still poor in the 
case of HisF, the double mutants of HisAF and HisA reached notable kcat/  
  A values 
of about 103 M-1s-1 and 104 M-1s-1. 
TrpF accomplishes the Amadori rearrangement of PRA via a general acid-base 
mechanism as outlined in Figure 3 [38]. The initial protonation of the furanose ring 
oxygen by Asp126 leads to the formation of a secondary aldimine. Acting as an 
electron sink, this Schiff base intermediate facilitates the deprotonation of the adjacent 
carbon atom by Cys7. In the final step, the generated enol form of CdRP tautomerizes 
to the corresponding keto form in an enzyme-independent manner [55]. 
 
Figure 3. Mechanism of PRA isomerase TrpF. 
In the initial step, the furanose ring oxygen is protonated by the general acid (Asp126). The 
thereby formed Schiff base intermediate acts as an electron sink and thus enables the general 
base (Cys7) to abstract a proton from the adjacent carbon atom. Finally, the enolamine form of 
CdRP spontaneously tautomerizes to the more stable keto form [38]. Modified from Figure 2, 
publication A. 
Since Cys7 and Asp126 act on different parts of the sugar moiety, they are situated 
at opposite sides of the catalytic face, namely at the C-terminal ends of β-strands 1 and 
6. As mentioned before, the isomerization of ProFAR catalyzed by HisA proceeds via 
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an identical reaction mechanism [38]. In addition, HisA and HisF share essential 
features of the active site like type and location of catalytically acting residues [32, 33]. 
So, it seems tempting to assume that the enzymatic mechanism observed for TrpF also 
holds for the PRAI activities engineered on HisA, HisF and HisAF. Accordingly, 
mutational studies proofed aspartate residues corresponding to Cys7 in TrpF crucial to 
PRAI activity (Asp8 in HisA and HisAF, Asp11 in HisF) [36, 54]. Subsequently 
performed docking studies revealed that these indispensable amino acids are perfectly 
located to act as general bases, as PRA is exclusively anchored in the C-terminal 
phosphate binding pocket also used by TrpF [36]. However, attempts to identify an 
appropriate general acid at the opposite barrel side failed. The only contemplable 
candidates – the aforementioned aspartate residues in β-strand 5 and βα-loop 6 – are 
mutated to valine in the best performing enzyme variants. To solve this apparent 
paradox, the artificially established PRAI activity was further investigated by pH-
dependent activity measurements, crystal structure analysis and molecular dynamics 
(MD) as well as mixed quantum and molecular mechanics (QM/MM) calculations. 
2.1.2 Summary and discussion 
pH rate profiles have been shown to provide valuable insights into enzymatic reaction 
processes [56, 57]. Hence, to mechanistically compare naturally evolved and artificially 
designed PRAI activity, the turnover numbers kcat of TrpF and the best performing 
mutant HisA_D127V+D169V were measured as a function of pH (Figure 4).
 
Figure 4. pH dependence of kcat for TrpF (A) and HisA_D127V+D169V (B). 
Turnover numbers were recorded at 15 °C using the buffer systems MES/NaOH (triangles 
down), HEPES/NaOH (circles), Tricin/NaOH (squares) and Glycin/NaOH (triangles up). 
Standard deviations, arising from at least three independent measurements, were determined 
across the whole pH range and are indicated, unless error bars are smaller than data symbols. 
The solid lines result from fitting the data to equation 1, publication A (panel A; TrpF) and 
equation 2, publication A (panel B; HisA_D127V+D169V), respectively. Thus, pKa values of 7.6 ± 
0.1 and 8.9 ± 0.1 for TrpF and 7.2 ± 0.1 for HisA_D127V+D169V were obtained. Modified from 
Figure 3, publication A. 
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As expected for a general acid-base catalysis, the kcat-pH-profile of TrpF adopts a bell-
shaped curve (Figure 4A). The ascending limb can be ascribed to an ionizable basic 
group which needs to be deprotonated to gain full activity, whereas the descending 
limb is distinctive of an acid which loses activity upon deprotonation with increasing 
pH. After fitting the data to equation 1, publication A, pKa values of 7.6 ± 0.1 (base) and 
8.9 ± 0.1 (acid) were obtained. While the former can easily be assigned to Cys7 [58], the 
latter only matches Asp126, if assuming a strong pKa perturbation [59]. It cannot be 
excluded that the higher pKa value reflects the phosphate group of PRA, whose 
deprotonation might cause an unfavorable change in substrate positioning and 
therefore reduce the overall reaction velocity. Interestingly, the kcat-pH-profile of 
HisA_D127V+D169V merely consists of a descending limb (Figure 4), as do the curves 
determined for HisA_D127V and HisA_D169V (Figure 3, publication A). Fitting the data 
to equation 2, publication A revealed an underlying pKa value of 7.2 ± 0.1. The exclusive 
presence of an acidic branch indicates that the performance of the associated general 
acid is rate-limiting for catalysis even at low pH values. Therefore, distinct differences 
seem to exist between the reaction mechanisms of TrpF and the PRAI active HisA 
variants, more precisely in the nature of the general acid. 
Recently, crystal structures with bound ligand substantially contributed to deci-
phering the catalytic mechanisms of PRA isomerases TrpF and PriA [28, 60]. In both 
cases, the stable product analogue reduced CdRP (rCdRP), whose keto moiety has been 
converted to an alcohol (Figure 2, publication A), was used instead of the labile substrate 
PRA [61]. Titration studies showed that HisF_D130V+D176V and rCdRP form a 
stoichiometric and highly affine complex (Figure S2, publication A). The thermodynamic 
dissociation constant (Kd) of 0.2 µM is comparable to that observed for TrpF [62], and 
by far surpasses the rCdRP affinities of all other PRAI active variants [36, 51]. As a 
consequence, HisF_D130V+D176V was crystallized in the presence of rCdRP, and a 
structure of the complex could be resolved at 1.9 Å (Figure 5). Although HisF in 
principle contains two phosphate binding sites, rCdRP is solely fixed at the C-terminal 
one (Figure 5A). The observed binding preference is perfectly in line with a previously 
published model obtained by docking PRA into the apo structure of the PRAI active 
mutant HisA_H75Y+F111S+D127V+D169V [36]. Furthermore, the C-terminal binding 
mode implicates a proper positioning of Asp11 to act as the general base. Its 
carboxylate group is separated 4.9 Å from the respective C4 atom of rCdRP, which 
compares well with the distance of 3.9 Å determined between the sulfhydryl group of 
Cys7 and the C4 atom of rCdRP in the TrpF complex [38]. Hence, these findings 
substantiate mutational studies which prove not only Asp11 in HisF but also the 
equivalent Asp8 residues in HisA and HisAF essential for PRA isomerization [36, 54].
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Figure 5. Crystal structure of HisF_D130V+D176V with bound product analogue rCdRP. 
A: A ribbon representation of HisF_D130V+D176V is shown in grey. A view on the active site 
reveals that rCdRP is anchored in the C-terminal phosphate binding site, which is composed of 
the backbone atoms of Gly177, Gly203, Ala224 and the side chain of Ser225 (interactions are 
indicated by dashed lines). Consequently, Asp11 is properly positioned to act as a base 
(illustrated by a dashed line). Due to the introduced residues Val130 and Val176, the only 
remaining candidates for the catalytic acid are Asp11 and the phosphate and carboxylate part of 
rCdRP (shown as spheres). B: The omit electron density (Fo–Fc) for the ligand rCdRP is 
contoured at 1.5σ. PDB ID: 4ewn. Taken from Figure 4, publication A. 
A corresponding general acid at the opposite barrel side, however, is looked for in 
vain. Instead, the crystal structure affords three alternative acid candidates: the already 
mentioned Asp11 as well as the phosphate and carboxylate group of the ligand (Figure 
5A). If Asp11 were to play a dual role in catalysis, PRA would have to adopt a position 
which allows for the initial protonation of its furanose ring oxygen. In the appropriate 
binding mode, the anthranilate moiety of PRA points down the central β-barrel – a 
geometry, though, which was shown to be energetically highly unfavorable as it leads 
to the ejection of PRA from the active site of HisF_D130V+D176V during MD 
simulations (data not shown). The phosphate group of rCdRP, in turn, is tightly 
anchored in the phosphate binding pocket via several hydrogen bond interactions and 
thus seems to be rather rigid (Figure 5A). The same applies to the adjacent hydroxyl 
group, which corresponds to the ring-oxygen in PRA. Accordingly, a high electron 
density is observed for this ligand part (Figure 5B), rendering the phosphate group 
unlikely to be involved in catalysis. In contrast, the remaining acid candidate, which is 
the anthranilate moiety of the ligand, exhibits a low electron density. The 
accompanying high grade of conformational flexibility might facilitate an internal 
proton transfer to the furanose ring oxygen, which would then constitute a case of 
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"substrate-assisted catalysis" (SAC) [63]. SAC has so far been discovered in enzymes 
like GTPases, type II restriction endonucleases, serine proteases and aminoacyl-tRNA 
synthetases [63-66]. Indeed, SAC has been considered before to play a role in the 
catalytic mechanism of artificially designed PRAI activity [36, 67].  
A straightforward approach to experimentally verify the hypothesis of SAC would 
be to remove the putative functional group of the substrate in order to impair catalysis 
[65]. In the present case, the carboxylate of PRA could be replaced by a non-reactive 
amide group. However, attempts to enzymatically synthesize phosphoribosylanthra-
nilic amide from anthranilic amide and phosphoribosyl-α1-pyrophosphate by anthra-
nilate phosphoribosyl transferase failed, which led to a focus on computational inves-
tigations, namely MD simulations and QM/MM calculations. MD simulations have 
been successfully applied to differentiate active from inactive enzyme designs [24, 68] 
and are a valuable tool for identifying mechanistically relevant conformations [69, 70]. 
Regarding biological systems, QM/MM calculations are the method of choice to probe 
proposed reaction mechanisms and get detailed information about the underlying 
activation barriers [71, 72]. Hence, a combination of both techniques is well-suited to 
elucidate enzyme mechanisms [69, 73] and should further substantiate the postulation 
that PRA is involved in its own conversion. 
If the anthranilic acid moiety of PRA indeed initiates the Amadori rearrangement 
by protonation of the furanose ring oxygen, two requirements have to be fulfilled: the 
proton transfer must be geometrically feasible and the pKa of anthranilic acid has to be 
in the right range to act catalytically. In order to examine both prerequisites, MD 
simulations were performed with the variants HisA_D127V, HisA_D169V and 
HisA_D127V+D169V, which feature higher catalytic activities than the respective HisF 
and HisAF mutants. Furthermore, wild-type HisA served as a reference. For all 
molecular simulations, two different binding modes of PRA were assumed (Figure 6A): 
in binding mode 1, the carboxylic acid group points towards the furanose ring oxygen 
and thus should be able to transfer a proton to the sugar moiety, at least with the 
assistance of a bridging water molecule. On the other hand, the anthranilic acid group 
is rotated through 180° in binding mode 2, resulting in a large spatial separation of the 
reactive substrate parts. Here, an internal proton transfer is considered to be highly 
unlikely. As judged by the resulting binding energies, HisA wild-type does not 
differentiate between mode 1 and 2 (Figure 6B). However, all PRAI active HisA 
variants clearly favor the productive binding mode 1 over the non-reactive binding 
mode 2 where the strongest preference can be observed for the single mutant 
HisA_D127V and for HisA_D127V+D169V. Furthermore, it had to be checked
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Figure 6. MD simulations of HisA, HisA_D127V, HisA_D169V and HisA_D127V+D169V 
with bound PRA. 
A: Two binding modes of PRA with opposing orientations of the anthranilic acid moiety were 
considered. B: Averaged energies of binding mode 1 (E(1)) and binding mode 2 (E(2)) were 
subtracted and differences are shown as bars for all proteins. The more negative the energy the 
stronger the preference for binding mode 1. At least three independent MD simulations were 
performed, mean energy values were determined and subsequently averaged for each mode 
and protein. A t-test ensured that the mean energy values attributed to the two modes are 
different with statistical significance for all three HisA variants (P ≤ 0.029). C: For the productive 
binding mode 1, pKa values of anthranilic acid were determined by PROPKA [74]. PDB IDs of 
used structures: HisA wild-type and HisA_D169V (modeled onto the wild-type scaffold): 1qo2; 
HisA_D127V: 2cff; HisA_D127V+D169V: 2w79. Taken from Figure 5, publication A. 
whether the pKa values of the anthranilic acid moiety allow for repeated proton 
donation and acceptance. To this end, the structures obtained with PRA bound in 
mode 1 were used to determine the respective pKa values by PROPKA [74]. Since 
anthranilic acid exhibits a pKa of only 2.05 in aqueous solution, its acidic strength 
needs to be significantly lowered when bound to the protein cavities. While in the 
background of HisA wild-type an even lower pKa of 1.3 is predicted, the introduced 
mutations seem to generate a more hydrophobic environment and therefore indeed 
cause the desired pKa-shift: the pKa values range between 4.2 and 5.8, with the largest 
changes observed for HisA_D169V and for HisA_D127V+D169V (Figure 6C). 
Therefore, also the second requirement for catalysis is met and the MD data are in line 
with the hypothesis of SAC. Moreover, the simulations suggest that the single point 
mutations D127V and D169V contribute to catalysis in a different manner: D127V 
mainly enables the positive discrimination of binding mode 1 (Figure 6B), whereas 
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D169V primarily elevates the pKa value of the anthranilic acid moiety (Figure 6C). The 
double mutant HisA_D127V+D169V combines both attributes and consistently 
displays the highest catalytic efficiency. Analogously conducted MD simulations with 
HisF_D130V+D176V further reinforce the obtained results, as the activating exchanges 
also induce a distinct preference for binding mode 1 and a marked upshift of the pKa of 
anthranilate (Figure S4, publication A). Consequently, SAC seems to be the basis for PRA 
isomerization on the scaffolds of both HisA and HisF. 
Finally, QM/MM calculations should proof the suggested catalytic mechanism 
and reveal energetics along the reaction pathway [69, 71-73]. Starting up with PRA 
bound to HisA_D127V+D169V in mode 1, a direct proton transfer comes along with a 
virtually too high energy barrier of more than 50 kcal/mol. As observed for other 
enzymatically catalyzed substrate protonations, however, a bridging water molecule is 
able to mediate the transfer process [75, 76] (Figure 7). Two steps are therefore neces-
 
Figure 7. QM/MM calculations of HisA_D127V+D169V with PRA bound in mode 1. 
Energy barriers were calculated for a water-mediated proton transfer within PRA. The reaction 
process includes two separate steps: beginning with PRA in binding mode 1, the carboxylic acid 
group protonates the bridging water molecule (left reaction coordinate). Subsequently, the 
generated hydronium ion is able to donate a proton to the furanose ring-oxygen (right reaction 
coordinate). The three involved reaction states are shown as insets. PDB ID of 
HisA_D127V+D169V: 2w79. Taken from Figure 6, publication A. 
sary to open the sugar moiety of PRA: the anthranilic acid moiety initially donates a 
proton to the adjacent water molecule and thus generates a hydronium ion, which is 
then capable of protonating the furanose ring oxygen. The associated energy costs 
amount to 10 kcal/mol and 15 kcal/mol, respectively, and are thus in conformity with 
the energetic demands of known water-mediated proton transfers [75, 76]. Taken 
together, the QM/MM calculations confirm that the anthranilic acid moiety of PRA can 
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take over the task of the general acid from an energetic point of view and underpin the 
mechanism of SAC. 
In order to catalyze the Amadori rearrangement of PRA, an enzyme basically requires 
two appropriate positioned residues acting as general acid and base, respectively [38]. 
However, as PRA itself brings along a carboxylic acid group which probably is capable 
of slipping into the role of the catalytic acid, the isomerization of PRA only demands a 
single base and thus follows a rather simple reaction mechanism. Accordingly, as 
mentioned in the introduction, this particular reaction could readily be established on 
various scaffolds, including the artificially designed and initially inert proteins HisAF 
and Sym2 [36, 37] as well as the enzyme glutamine phosphoribosylpyrophosphate 
amidotransferase (PurF), which is unrelated to TrpF in sequence, structure and 
catalytic mechanism [21]. PurF only exhibits a preexisting molecular recognition site 
for the phosphoribosyl moiety of PRA and an aspartate residue properly positioned to 
take over the part of the general base, but no obvious acid candidate could be 
identified. It is hence plausible to assume that the PRAI activity of PurF is also based 
on the mechanism of SAC. Furthermore, even the wild-type enzymes TrpF and PriA 
are not completely dependent on their catalytic acids. When replacing Asp126 (TrpF) 
and Asp175 (PriA) by asparagines, the remaining catalytic efficiency kcat/  
  A is still 
moderate in the case of TrpF (102 M-1s-1) [38] and even comparable to the best 
performing HisA mutant in the background of PriA (104 M-1s-1) [36, 60]. In contrast, the 
removal of the catalytic bases (C7A in TrpF and D11N in PriA) completely abolishes 
TrpF activity [38] and extremely reduces the catalytic efficiency of PriA to 59 M-1s-1 [60]. 
The residual activities of both TrpF_D126N and PriA_D175N may be ascribed to an 
escape route in which the anthranilate group of PRA functionally replaces the mutated 
catalytic acid. As this non-native reaction pathway is less demanding than the natural 
mechanisms of TrpF or PriA, SAC might have been a starting point or functional 
intermediate in the evolution of enzyme-catalyzed PRA isomerization [63]. 
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2.2 Project B: Characterization of a HisF enzyme from the 
Paleoarchean era 
2.2.1 Introduction and objective 
The earth is approximately 4500 million years (4.5 Gyr) old and according to geologic 
evidence, life began about 3.5 Gyr ago in the Archean era [77]. Biological systems have 
been evolving ever since and have given rise to unique enzymes with specific and 
sophisticated catalytic features. These include complicated enzyme mechanisms with 
multiple reaction and conformational intermediates [78-80] and tight coordination of 
catalysis in multienzyme complexes due to, for example, substrate channeling and 
allosteric communication [81, 82]. Furthermore, large protein assemblies are observed 
in molecular machines such as chaperones or the proteasome, which are involved in 
protein folding and degradation, respectively [83, 84]. From an evolutionary point of 
view, it is an intriguing question, when this biological complexity developed [85]. It is 
widely accepted that the three domains of life – the Archaea, the Bacteria, and the 
Eucarya – originated from a last universal common ancestor (LUCA) [86]. Yet, the 
nature of this predecessor has been lively debated on [87, 88]. Based on sequence 
comparisons, the LUCA was claimed to be a rather simple entity- an assumption that 
appears intuitively plausible [86, 88, 89]. In contrast, the majority of investigations, also 
considering three-dimensional protein structures and coevolutionary aspects, are in 
favor of a complex LUCA resembling extant organisms [87, 90-95]. Direct experimental 
evidence for this conjecture, though, remained elusive, as molecular fossils are rare and 
difficult to interpret [77]. 
Interestingly, Pauling and Zuckerkandl suggested half a century ago that it should be 
possible to infer ancestral protein sequences from the amino acid compositions of their 
modern descendants [96]. Meanwhile, a technique called ancestral sequence recon-
struction has been established and has enabled the study of extinct proteins, thus 
linking molecular and evolutionary biology [85, 97-99]. The underlying approach 
comprises three different steps and is outlined in Figure 8 [97]. Initially, a sequence set 
of the protein of interest is used to generate a multiple sequence alignment, which in 
turn provides the basis for the calculation of a phylogenetic tree. As the phylogeny 
reflects the evolutionary relationship of all extant proteins, every node in the tree 
corresponds to an individual ancestral sequence. Furthermore, branch lengths are a 
measure of the time lying between the connected sequences. Consequently, given the 
overall tree topology, an evolutionary model which takes into account the rates and 
probabilities of amino acid substitutions can be used to infer all ancestral sequences. 
Both the construction of the phylogenetic tree and the final calculation of extinct
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Figure 8. Strategy of ancestral sequence reconstruction. 
Starting up with a selected set of sequences, a multiple sequence alignment is generated. Next, 
the aligned sequences are used to infer a phylogenetic tree whose topology and branch lengths 
define the evolutionary relationship of all extant sequences. Moreover, every node in the tree 
corresponds to an ancestral sequence. Finally, the predecessors can be reconstructed by 
applying a model for the rates and probabilities of amino acid substitution at each site. 
sequences is usually based on likelihood methods, hence deducing the most probabilis-
tic phylogeny and ancestors [100-102]. In order to derive an accurate design, the whole 
reconstruction process needs to be performed with care. For example, when selecting 
the protein sequences, it should be considered that horizontal gene transfer frequently 
occurred among different prokaryotes [103]. Moreover, tree nodes should exhibit a 
reliable statistical confidence and the overall tree topology should resemble the 
universal consensus tree of life [103, 104]. Regarding the underlying evolutionary 
model of the final reconstruction step, a variable substitution rate along lineages and 
the differentiation of distinct sequence sites in their substitution probabilities have 
proven beneficial [102, 105]. 
So far, various proteins have been resurrected, including the elongation factor Tu 
[106, 107], several visual [108-110] and fluorescent pigments [111, 112], and plenty of 
steroid hormone receptors [113-119]. Reconstructions also brought about functional 
enzymatic ancestors of alcohol dehydrogenases [120], glucosidases [121], nucleosid 
diphosphate kinases [122] or methyltransferases [123]. The generated biomolecules 
could be used to address diverse questions about the ecological features of early life 
[105-107, 122, 124] and revealed crucial aspects of molecular evolution. Thus, light was 
shed upon mechanisms of gene duplication [121], the role of epistatic mutations in the 
course of evolution [110, 111, 114, 118], and the development of ligand and substrate 
specifity [113, 115-117, 119, 123, 125]. Recently, formation of the hexameric transmem-
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brane ring of the fungal V-ATPase proton pump was investigated [126]. It could be 
demonstrated that the composition of three paralogous protein subunits, specifically 
found in fungi, emerged from a simpler two-component system via gene duplication, 
gene loss and subsequent functional adaptation hundreds of millions of years ago. 
However, in order to assess the degree of complexity already present at evolutionary 
stages preceding the specification into the three domains of life, reconstructions have to 
go further back in time. Along these lines, a thioredoxin enzyme being at least 3.5 Gyr 
old was resurrected and the mechanism of disulfide bond reduction was examined 
[127]. Strikingly, the ancient enzyme acted not only by means of a simple nucleophilic 
bimolecular mechanism, but also a single electron transfer mechanism and a substrate 
binding and rearrangement reaction were observed. Thus, the complex reduction 
chemistry of modern thioredoxin enzymes had already been established by 3.5 Gyr 
ago. 
It has been assumed that primary metabolic pathways like histidine biosynthesis 
had been assembled before the LUCA appeared [11, 128]. Consequently, an appropri-
ate set of protein sequences should allow for the reconstruction of metabolic enzymes 
resembling those of the LUCA. A respective approach was recently reported for the 
HisF subunit of ImGP synthase [104]. As the synthase HisF forms an obligate hetero-
dimer with the glutaminase HisH in prokaryotes [41, 129], a concatenation of both 
sequences was chosen as a basis for the reconstruction process to increase the phylo-
genetic signal. The resulting multiple sequence alignment contained 87 sequences, 
including the clades Crenarchaeota, Actinobacteria, Chlorobi, Cyanobacteria, 
Firmicutes, Proteobacteria, and Thermotogae (Figure S1, publication B). On this basis, a 
phylogenetic tree was calculated and rooted between the superkingdoms Archaea and 
Bacteria. The protein sequence corresponding to the root was reconstructed and will be 
termed LUCA-HisF hereafter. LUCA-HisF is approximately 3.5 Gyr old and thus 
among the most ancient predecessors inferred so far [106, 125, 127]. According to 
BLAST [130], LUCA-HisF differs in 55 of 250 amino acids (22 %) from its closest living 
relative, which is HisF from Thermovibrio ammonificans. Strikingly, this bacterium was 
isolated from a deep-sea hydrothermal vent [131], a geochemical habitat whose unique 
environment has repeatedly been associated with the origin of life [77, 132].  
In modern HisF enzymes, binding of the substrate PRFAR triggers an allosteric 
signal and hence enhances the catalytic efficiency of the interacting glutaminase 
subunit HisH by up to several hundredfold [45, 49]. Furthermore, the ammonia 
produced by HisH is transported to the active site of HisF through a molecular channel 
spanning the whole lengths of the (βα)8-barrel fold of HisF (Figure 1, publication B) [42, 
46, 49]. These exceptional catalytic features provide an ideal foundation for 
experimentally testing the grade of sophistication reached in the LUCA era. Along 
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these lines, the physical and catalytic properties of LUCA-HisF were investigated 
within the scope of this project. 
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2.2.2 Summary and discussion 
The gene coding for LUCA-HisF was optimized for expression in Escherichia coli, 
synthesized (Life Technologies), and cloned into an expression plasmid. Production in 
E. coli yielded predominantly soluble protein, which was purified in a three-step 
process via ion exchange chromatography, ammonia sulfate precipitation, and size 
exclusion chromatography. Notably, about 30 mg of protein were obtained per liter of 
culture. Subsequently, LUCA-HisF was characterized by means of several biophysical 
methods to assure its structural and functional integrity. 
Initially, LUCA-HisF was crystallized using the hanging drop vapor diffusion method 
and its structure was resolved at a resolution of 1.48 Å. For this purpose, a homology 
model of LUCA-HisF was built on the structure of HisF from T. maritima (tmHisF) 
(PDB ID: 1thf) and served as a template for molecular replacement [133]. As expected, 
LUCA-HisF adopts a canonical (βα)8-barrel fold, comparable to known structures of 
the HisF enzymes from Pyrobaculum aerophilum (PDB ID 1h5y), Thermus thermophilus 
(PDB ID 1ka9), and T. maritima. Thus, when aligning each of these tertiary structures 
with the structure of LUCA-HisF through STAMP [134], low overall root-mean-square-
deviation (rmsd) values ranging from 1.14 Å to 1.43 Å were obtained. Moreover, in 
accordance with the postulated evolution from a half-barrel precursor via gene dupli-
cation and fusion [32], LUCA-HisF displays a clear twofold symmetry. Superposition 
of its N-terminal (βα)1-4 and C-terminal (βα)5-8 module resulted in a rmsd value of 
merely 1.68 Å. However, similar values of 1.27 Å to 1.69 Å were obtained for the 
corresponding analyses of the three extant HisF proteins, indicating that the main 
structural evolution of the (βα)8-barrel fold had been completed 3.5 Gyr ago. Among 
the 87 protein sequences used for reconstruction, 78 of 250 residues are less than 50 % 
conserved. While these variable positions are primarily located at the rim of the barrel, 
the functionally important activity and stability face are widely unaltered (Figure 9). 
Hence, LUCA-HisF contains indispensable amino acids like the catalytically acting 
aspartate residues 11 and 130, lying at the C-terminal ends of β-strands 1 and 5, 
respectively (Figure 9A) [41], and the stabilizing salt-bridge cluster at the opposite side 
of the barrel which forms the gate to the ammonia channel (Figure 9B) [42, 49, 135]. 
Moreover, the two co-crystallized phosphate ions occupy the N- and C-terminal 
phosphate binding site and thus mimic the terminal phosphate groups of the substrate 
PRFAR. 
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Figure 9. Crystal structure of LUCA-HisF (PDB ID: 4evz). 
The surface representations of LUCA-HisF are colored according to the amino-acid conserva-
tion deduced from a multiple sequence alignment of all protein sequences used for resurrection 
(red: variable; white: strictly conserved). The conservation values (0-11) were determined 
through Jalview [136]. A: View on the activity face. Side chains of the catalytically essential 
residues Asp11 and Asp130 as well as bound phosphate ions are shown as sticks. B: Stability 
face and ammonia tunnel gate. Arg5, Glu46, Lys99 and Glu167 form a stabilizing salt  bridge 
cluster at the bottom of the barrel, which defines the entrance to the ammonia channel (side 
chains are depicted as sticks; electrostatic interactions are indicated by dashed lines). Taken 
from Figure 2, publication B. 
After closely examining the crystal structure of LUCA-HisF, its thermal and confor-
mational stability were determined. Along these lines, the heat-induced loss of 
secondary structure was probed by a decrease in the far-UV circular dichroism (CD) 
signal, and overall thermal unfolding was monitored by differential scanning 
calorimetry (DSC). The combination of both methods showed that LUCA‐HisF 
thermally unfolds in an irreversible two‐step process with apparent transition 
midpoints of about 70 °C and 100 °C (Figure S3A+B, publication B). Although the 
observed transitions could not be assigned to particular structural changes, it can be 
concluded that LUCA-HisF features a high resistance to heat. Next, the thermo-
dynamic stability of LUCA-HisF was analyzed by guanidinium chloride-(GdmCl)-
induced equilibrium unfolding/refolding transitions (Figure 10). Starting either with 
folded (dissolved in buffer) or unfolded (dissolved in 6 M GdmCl) protein, the 
concentrations of GdmCl were adjusted between 0 and 5 M, and after equilibration, the 
loss or gain of tertiary structure was quantified by Trp/Tyr fluorescence. The data 
points for unfolding and refolding coincide, demonstrating that GdmCl-induced 
unfolding is reversible. Moreover, both processes are adequately described by the two-
state model, enabling thermodynamic analysis to yield the Gibbs free energy of 
unfolding (ΔGD), the concentration of GdmCl required to denaturate half of the protein 
([D]1/2), and the cooperativity of unfolding (m-value) [137]. LUCA-HisF exhibits a 
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Figure 10. GdmCl-induced equilibrium unfolding/refolding transitions of LUCA-HisF. 
Unfolding transitions (black circles) were started with folded protein, whereas protein used for 
refolding transitions (white circles) was previously unfolded in 6 M GdmCl. After adjusting to 
the respective GdmCl concentration and equilibration, the loss or gain of tertiary structure was 
monitored by protein fluorescence at 320 nm (excitation at 280 nm). Data were analyzed by the 
two-state model [137], where the corresponding fits are represented by continuous lines and the 
baselines for the pure native and unfolded state are indicated by dashed lines. The resulting 
thermodynamic parameters are given in Table S2, publication B. Taken from Figure 3, publication 
B. 
moderate ΔGD value of 18 kJ mol
-1 and a transition midpoint [D]1/2 at 1.2 M GdmCl and 
therefore is less stable than tmHisF [138]. However, more importantly, LUCA-HisF 
unfolds with a high cooperativity of 15 kJ mol-1 M-1, which is comparable to the m-
value of tmHisF and thus is indicative of a compact structure [138]. Moreover, 
subsequently performed folding kinetics demonstrate that LUCA-HisF and tmHisF 
share a common sequential folding mechanism, including the rate-limiting step 
(Figures S4B+S5+S6, publication B). This mechanism also holds for the artificially 
designed proteins Sym1 and Sym2, which should temporally precede LUCA-HisF due 
to their marked internal twofold rotational symmetry [34]. Hence, also the folding 
mechanism of the (βα)8-barrel structure had apparently already been evolved in the 
LUCA era. 
The ultimate validation of a resurrected enzyme is the verification of its catalytic 
function. In the case of HisF, enzymatic activity can be measured spectrophotome-
trically in the presence of saturating concentrations of externally added ammonia 
(ammonia-dependent cyclase activity) [44]. Surprisingly, the catalytic efficiency 
(kcat/  
  FA ) of LUCA-HisF is as high as the kcat/  
  FA  values observed for extant 
ImGP synthase subunits, mainly due to its low Michaelis constant   
  FA  (Table 1). 
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Table 1. Steady state kinetic constants of LUCA-HisF/zmHisH in comparison to extant ImGP 
synthase pairs. 
Ammonia-dependent cyclase activity 
 kcat [s
-1]   
  FA  [µM] kcat/  
  FA  [M-1s-1] 
LUCA-HisF 0.078 (± 0.003) 0.29 (± 0.04) 2.8 (± 0.3) x 105 
tmHisFa 1.2 3.6 3.3 x 105 
ecHisFb 5.7 21 2.7 x 105 
scHisFc 0.8 55 1.5 x 104 
Glutamine-dependent cyclase activity 
 kcat [s
-1]   
  FA  [µM] kcat/  
  FA  [M-1s-1] 
LUCA-HisF/ 
zmHisH 
0.058 (± 0.006) 0.36 (± 0.07) 1.6 (± 0.3) x 105 
tmHisF/tmHisHa 1.1 2.0 5.5 x 105 
ecHisF/ecHisHb 8.5 1.5 5.7 x 106 
scHisF/scHisHc 5.4 5.0 1.2 x 106 
Glutaminase activity 
 kcat [s
-1]   
Gln [mM] kcat/  
Gln [M-1s-1] 
LUCA-HisF/ 
zmHisH 
0.21 (± 0.03)  1.9 (± 0.9) 1.2 (± 0.3) x 102 
tmHisF/tmHisHa 0.1 0.8 1.3 x 102 
ecHisF/ecHisHb 9.1 0.2 3.8 x 104 
scHisF/scHisHc 6.9 1.8 3.8 x 103 
Stimulation of glutaminase activity 
 
kcat [s
-1]  
(without ProFAR) 
kcat [s
-1]  
(ProFAR saturated) 
Stimulation factord 
LUCA-HisF/ 
zmHisH 
3.85 (± 0.04) x 10-2  0.483 (± 0.006) 13 
tmHisF/tmHisHa 3.3 x 10-4 0.1 303 
ecHisF/ecHisHb 7.0 x 10-2 2.7 39 
scHisF/scHisHc 5.5 x 10-3 6.9 1255 
a: Data for ImGP synthase from T. maritima (tm) were taken from [49]. 
b: Data for ImGP synthase from E. coli (ec)  were taken from [44]. 
c: Data for ImGP synthase from S. cerevisiae (sc) were taken from [45]. 
d: The stimulation factor is the quotient kcat (ProFAR saturated)/kcat (without ProFAR). 
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The activity of LUCA-HisF also was confirmed by in vivo complementation assays with 
an auxotrophic E. coli strain lacking the hisF gene. ΔhisF cells are not able to produce 
histidine and thus do not grow when plated on minimal medium without amino acids. 
However, after transformation with a plasmid containing the LUCA-HisF gene, visible 
colonies are formed within 24 hours. It is widely accepted that enzyme precursors 
possessed a broad substrate specificity [139]. Accordingly, recently resurrected lacta-
mases process an expanded substrate repertoire and support the notion that modern 
enzyme specialists evolved from ancient generalists [125]. Therefore, LUCA-HisF was 
tested for its ability to catalyze the reactions of the sugar isomerases HisA and TrpF. As 
outlined in chapter 2.1, HisA precedes HisF in histidine biosynthesis and both enzymes 
are strongly related in terms of sequence and structure [32]. As to the PRA isomerase 
TrpF, a single amino acid substitution is sufficient to establish PRAI activity on HisF, 
suggesting an evolutionary relationship [50, 54]. Despite these similarities, both in vivo 
complementation assays and in vitro spectroscopical measurements demonstrated that 
LUCA-HisF catalyzes neither the HisA nor the TrpF reaction. 
The catalytic sophistication of the synthase HisF can only completely be assessed 
in conjunction with an interacting glutaminase HisH. It is plausible to assume that 
LUCA-HisF is able to interact with extant glutaminases, since large sections of its 
protein interface, which is located at the stability face (Figure 1, publication B), are 
conserved (Figure 9A). Indeed, fluorescence titration revealed an interaction between 
LUCA-HisF and HisH from Zymomonas mobilis (zmHisH). As zmHisH contains a 
tryptophan residue at the protein interface, stepwise addition of a tryptophan-free 
variant of LUCA-HisF gradually shielded this particular residue from the solvent and 
thus induced a hypsochromic shift of the fluorescence signal [41] (Figure 11A). 
Analysis of the resulting titration curve showed that LUCA-HisF and zmHisH form a 
stoichiometric and affine complex, whose thermodynamic dissociation constant Kd is 
113 nM. 
With a glutaminase partner in hand, the synthase activity of LUCA-HisF could be 
measured in the presence of zmHisH and saturating concentrations of glutamine 
(glutamine-dependent cyclase activity). Notably, the determined kcat and   
  FA  values 
compare well with the catalytic parameters obtained for the ammonia-dependent 
reaction (Table 1), suggesting that externally added ammonia can equivalently be 
replaced by ammonia produced by hydrolysis of glutamine. As a consequence, the 
active sites of zmHisH and LUCA-HisF seem to be connected by an extended ammonia 
channel, as known from extant HisF/HisH pairs [42, 43, 49]. Moreover, in the presence 
of LUCA-HisF and saturating amounts of the substrate analogue ProFAR, 
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Figure 11. Interaction and glutaminase activation of LUCA-HisF and zmHisH. 
A: The fluorescence titration curve was obtained by gradually adding a tryptophan-free variant 
of LUCA-HisF to 7 µM zmHisH and monitoring the emission change at 318 nm after excitation 
at 295 nm. The solid line represents a quadratic fit of the data points. Three independent 
titrations resulted in a Kd value of 113 ± 1 nM. B: Allosteric activation of zmHisH was deter-
mined in a discontinuous photometric assay at 363 nm. In identical setups, glutamine was 
incubated with zmHisH/LUCA-HisF at 25 °C both in the absence (circles) and presence 
(triangles) of ProFAR. Mean values and standard deviations of triplicate measurements are 
shown. As listed in Table 1, glutaminase activity of zmHisH is enhanced 13-fold in the presence 
of ProFAR. Taken from Figure 4, publication B. 
zmHisH processes glutamine nearly as efficient as other glutaminases (Table 1). In 
sum, these findings clearly demonstrate that LUCA-HisF forms a functional ImGP 
synthase complex with zmHisH. However, the most remarkable characteristic of extant 
HisF enzymes, namely the ability to allosterically increase the glutaminase activity 
upon substrate binding, still had to be analyzed. In principle, glutamine hydrolysis is 
monitored in a coupled enzyme assay with glutamate dehydrogenase, which oxidizes 
glutamate with the assistance of nicotinamide adenine dinucleotide (NAD+) or acetyl-
pyridine adenine dinucleotide (APAD+) and thus enables photometric detection at 
340 nm and 363 nm, respectively [41, 44]. Besides the substrate PRFAR and its 
analogue ProFAR, however, the coenzymes NAD+ and APAD+ were also shown to 
stimulate the glutaminase activity [49]. On this account, the production and 
quantification of glutamate had to be separated in a discontinuous assay, in order to 
determine the extent of glutaminase activation caused by the synthase with bound 
ProFAR [49]. Most strikingly, the corresponding measurements revealed that 
glutamine hydrolysis of LUCA-HisF/zmHisH is 13 times more efficient in the presence 
than in the absence of ProFAR (Figure 11B; Table 1). The magnitude of stimulation is 
comparably high as the allosteric activation reported for the ImGP synthase complex of 
E. coli and definitely remarkable for a non-natural ImGP synthase pair, even if 
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significantly higher stimulation effects were observed for the complexes from T. 
maritima and S. cerevisiae (Table 1).  
Although 3.5 Gyr old, LUCA-HisF constitutes an intact (βα)8-barrel protein, whose 
folding mechanism and overall structure is in no way inferior to modern HisF 
enzymes. In contrast to previously resurrected lactamases [125], LUCA-HisF does not 
show substrate promiscuity, but is a highly specific enzyme. Furthermore, together 
with the glutaminase zmHisH, LUCA-HisF forms a fully functional complex. Hence, 
LUCA-HisF exhibits all elements required for ammonia channeling and allosteric 
communication, indicating that these sophisticated catalytic concepts had already been 
evolved in the LUCA era and thus suggesting a rather complex metabolism at this 
early point in time. This notion is perfectly in line with the results obtained for 
resurrected thioredoxin enzymes [127] and also complies with the majority of 
theoretical investigations [87, 90-95]. 
The postulated existence of a functional ImGP synthase complex about 3.5 Gyr ago 
relies on the interplay between a resurrected synthase and an extant glutaminase. More 
direct evidence could be obtained, if a HisH protein from the LUCA era was used 
instead of zmHisH. As a concatenation of HisF and HisH sequences provided the basis 
for the reconstruction of LUCA-HisF [104], a putative HisH predecessor was inferred 
in an analogous manner. However, the protein was found to be completely insoluble 
under several expression conditions and even purification from inclusion bodies failed. 
The reconstruction was probably hampered by the low sequence conservation of extant 
HisH enzymes: In comparison to HisF proteins, twice as many amino acids are less 
than 50 % conserved. Even more problematically, HisH sequences significantly differ 
in their overall size, leading to systematic errors in the multiple sequence alignment 
and influences the accuracy of the final reconstruction step [140]. This problem could 
be circumvented by using a software called PRANK, which is superior to traditional 
alignment algorithms, as phylogeny is considered in the placement of gaps [140, 141]. 
Accordingly, PRANK was used to generate a more accurate multiple sequence 
alignment and to compute a protein sequence for LUCA-HisH (Figure S2, publication B). 
After gene synthesis (Life Technologies) and cloning into an expression plasmid, 
LUCA-HisH was expressed in E. coli cells. Although only 21 of its 226 residues are 
strictly conserved, LUCA-HisH was predominantly found in the soluble fraction and 
showed a high thermal stability. About 26 mg of the pure protein were obtained after 
purification via heat denaturation and Ni2+ affinity chromatography. The thermo-
stability of LUCA-HisH was further proven by heat-induced loss of the far-UV CD 
signal, resulting in a single transition with a midpoint of about 79 °C (Figure S3C, 
publication B). Remarkably, fluorescence titration revealed that LUCA-HisH forms a 
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stoichiometric complex with LUCA-HisF (Figure 12) – both proteins interact with a 
very high affinity represented by a Kd value of merely 4 nM.  
 
Figure 12. Interaction of LUCA-HisF and LUCA-HisH. 
5 µM LUCA-HisH were titrated with LUCA-HisF_W138Y+W156Y and the change in fluores-
cence emission was monitored at 318 nm (excitation at 295 nm). A quadratic equation was used 
to fit the data represented by the solid line. Three independent titrations resulted in a Kd value 
of 4 ± 2 nM. 
Despite this strong interaction, no enzymatic turnover could be determined when 
testing the LUCA-HisF/LUCA-HisH complex for the hydrolysis of glutamine and the 
glutamine-dependent cyclase activity, respectively. Thus, LUCA-HisH is inactive, which is 
probably to be ascribed to the indicated uncertainties in sequence reconstruction. 
Especially the numerous gaps observed in the alignment of HisH sequences (Figure S2, 
publication B) seem to negatively affect the overall accuracy of reconstruction. In 
contrast, the sequence lengths of the successfully reconstructed HisF and thioredoxin 
enzymes are very similar to the respective extant proteins. Therefore, in order to deal 
correctly with cases as difficult as HisH, the inference of ancestral sequences requires 
optimization of the placement and reconstruction of insertions and deletions. 
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2.3 Project C: Light regulation of PriA from Mycobacterium 
tuberculosis 
2.3.1 Introduction and objective 
The regulation of enzyme activity is a crucial factor for coordinating the vast array of 
cellular processes. Besides genetic control of enzyme synthesis, catalytic performance 
can directly be adjusted at the protein level through various regulatory mechanisms 
[142]. These include limited proteolysis as known from irreversible activation of serine 
proteases [143] and reversible covalent modifications like adenylation [144] and phos-
phorylation, which is widely used among prokaryotes and eukaryotes [145]. Further-
more, plenty of enzymes can be activated or inhibited by small metabolites. Most 
prominently, early catalytic steps of metabolic pathways are often allosterically 
inhibited by subsequently produced intermediates or by the end-products [146]. This 
so-called feedback inhibition has, for instance, been described for aspartate 
transcarbamoylase and anthranilate synthase, which catalyze the first steps of 
pyrimidine and tryptophan biosynthesis, respectively [147, 148]. In addition, enzyma-
tic activity can be controlled by external stimuli like osmotic pressure, pH-changes, 
oxygen and light. In general, stimulus-sensitive protein domains are able to transfer 
the extracellular signal to effector domains such as kinases or phosphodiesterases, thus 
initiating a cellular response [149, 150].  
Artificial control of enzyme activity would enable attractive applications for 
example in diagnostics and biosensoring and hence has been a long-pursued aim [151, 
152]. In search of a signal triggering the change in catalytic efficiency, light was proven 
an ideal tool, as it allows for non-invasive and spatiotemporal regulation of biological 
activity [153]. Three different strategies were applied to render enzymatic performance 
light-responsible [154]. Catalytically essential residues were caged with photolabile 
protecting groups, affording irreversible enzyme activation upon light irradiation 
[155]. Furthermore, the catalytic function of enzymes was controlled by genetic fusion 
with naturally occurring photoreceptors [152]. Finally, enzymatic activity was 
modulated in various ways by chromophores which undergo reversible photochemical 
transformations and therefore were termed photoswitches [151]. These chemical 
compounds were either randomly or site-selectively incorporated into enzymes in 
order to affect the active sites upon irradiation [156-158]. On the other hand, enzymes 
were embedded in photocontrollable environments like photoresponsive membranes 
or surfactants in a few cases [159, 160]. Although subjected to marked restrictions [151], 
these strategies indirectly control catalytic activity and thus dispense with the need for 
a covalent coupling step between protein and photoswitch. Along these lines, several 
Projects 
 
37 
 
approaches focused on the use of photosensitive enzyme inhibitors, which were 
designed on the basis of known inhibitors [161-164]. Despite numerous attempts to 
reversibly regulate enzymatic function by light, only few successful examples have 
been published to date [151]. 
The bisubstrate-specific enzyme PriA from Mycobacterium tuberculosis (mtPriA) 
constitutes a branch-point enzyme in amino acid biosynthesis [39]. mtPriA catalyzes 
two chemically equivalent sugar isomerization reactions within tryptophan and 
histidine biosynthesis, where the aminoaldoses PRA and ProFAR are converted to the 
corresponding aminoketoses CdRP and PRFAR (Figure 2). Since humans can produce 
neither tryptophan nor histidine, mtPriA is a potential target for anti-tuberculosis 
drugs [165, 166]. Due to these unique enzymatic properties, the current project was 
aimed at constructing light-controllable inhibitors of mtPriA. After harnessing 
available enzyme structures for the design of potential inhibitors, the molecules were 
synthesized, and photochemically and functionally characterized. 
2.3.2 Summary and discussion 
Recently solved crystal structures revealed that mt riA adopts a (βα)8-barrel fold with 
two special attributes [40, 60]. On the one hand, the active site comprises two opposite 
phosphate binding sites, which anchor the bi-phosphorylated substrate ProFAR 
(Figure 13A). Since high phosphate concentrations were shown to compete with 
substrate binding in related enzymes [36], potential inhibitors could probably be fixed 
through terminal phosphate groups. On the other hand, mtPriA exhibits an eye-
catching twofold rotational symmetry (Figure 13A), which is ascribed to its evolution 
from a (βα)4-half-barrel precursor via gene duplication and fusion [50]. Interestingly, 
an artificially designed protein with threefold rotational symmetry was co-crystallized 
with the threefold symmetric molecule tris(hydroxymethyl)aminomethane (Tris) [167]. 
It therefore seems plausible to assume that compounds containing a twofold axis of 
symmetry are particularly suited to bind to the active site of mtPriA. Merely two kinds 
of light-controllable scaffolds feature the desired symmetry and were considered for 
the structural core of mtPriA inhibitors: the isoelectronic stilbene [168] and azobenzene 
switches [169], and diarylethene [170]. Both stilbene and azobenzene undergo 
reversible trans-to-cis isomerizations. However, the cis isomer of stilbene is prone to an 
irreversible cyclization/oxidation reaction, rendering the scaffold unsuitable for the 
photoregulation of enzymes. Azobenzene is the most widely used photoswitch in 
biological systems [151, 169], although the underlying trans-to-cis isomerization is both 
incomplete and thermally reversible [154]. In contrast, irradiation of 1,2-dithienyl-
ethene (DTE) usually results in virtually complete photoconversion and thermally
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Figure 13. Structure of mtPriA and potential inhibitors based on the photoswitchable DTE 
scaffold. 
A: View along the twofold symmetry axis of the (βα)8-barrel enzyme mtPriA, which is depicted 
in ribbon representation (PDB ID 3zs4 [60]). The product PRFAR is fixed by the two opposite 
phosphate binding sites. The coordination of the phosphate groups is enlarged in the insets, 
where hydrogen bonds are indicated by dashed lines (for clarity, insets are shown in different 
orientations). Taken from Figure 1, publication C. B: The DTE scaffold can reversibly be switched 
between a ring-open and a ring-closed isomer through irradiation with UV and visible light, 
respectively. Potential DTE inhibitors of mtPriA were equipped with terminal phosphate 
(compounds 5, 6, 7) and phosphonate (compounds 12, 13) groups. 
stable photoisomers [162, 170]. Therefore, DTE was chosen as a scaffold and provided 
with terminal phosphate and chemically similar phosphonate anchors (Figure 13B). 
Due to the viable synthesis through Suzuki coupling (Scheme 1, publication C), all 
potential inhibitors contain phenyl linkers between the DTE core and the terminal 
anchor groups (Figure 13B). In order to ensure structural variety, phosphate groups 
were placed in ortho-, meta-, and para-position (compounds 5, 6, and 7), whereas 
phosphonate groups were limited to the meta- and para-position (compounds 12 and 
13). Energy minimizations of all compounds yielded distances of the phosphorous 
atoms between 15.8 and 19.6 Å (Scheme 2, publication C), which is in good accordance 
with the 16.9 Å observed for the mtPriA-PRFAR complex (PDB ID 3zs4 [60]). Only the 
energetically most favorable forms of compound 5 exhibited phosphate distances no 
longer than 12.3 Å. However, more extended conformers with higher energies were 
also populated. Hence, judged by their lengths, all designed molecules should be able 
to inhibit mtPriA. 
The DTE architecture can be toggled between a flexible, ring-open and a rigid, ring-
closed isomer through alternate irradiation with UV and visible light, respectively 
(Figure 13B) [170]. Thus, the switching properties of the synthesized compounds were 
examined to verify their photochemical integrity. As all DTE-phosphates and DTE-
Projects 
 
39 
 
phosphonates behaved virtually identical, merely the characterization of compound 6 
is described in the following and depicted in Figure 14.  
 
Figure 14. Representative photochemical characterization of compound 6. 
A: Change in the absorption spectrum upon irradiation with 312 nm light. The open form of 6 
(12.5 µM in 50 mM Tris/acetate pH 8.5) was irradiated in intervals of 2 s from 0 (black) to 30 s 
(pink). B: Repeated ring-closing/ring-opening cycles. DTE-phosphate 6 (12.5 µM in 50 mM 
Tris/acetate pH 8.5) was alternately irradiated with UV light (312 nm; 30 s) and visible light 
(> 420 nm; 15 min) and the absorption change was monitored at 525 nm. The open and closed 
isomer are depicted as black and pink dots, respectively C: Determination of the photo-
stationary state. HPLC chromatograms of compound 6 (100 µM in 50 mM Tris/acetate pH 8.5) 
without (black) and with (pink) irradiation at 312 nm for 30 s were recorded at 288 nm and 
superimposed. The respective absorption spectra of the main peaks are shown as insets. 
According to the peak intensities, 97 % of the closed isomer were formed by irradiation. 
When irradiated at 312 nm, meta-phosphate 6 immediately altered its absorption 
spectrum (Figure 14A). While the peak at 280 nm decreased, new maxima arose at 350 
nm and especially at 525 nm, turning the initially colorless solution pink. All spectral 
changes were completed after 30 s. Subsequently, the original absorption spectrum 
could be fully restored through irradiation with visible light for 15 min. Moreover, this 
switching cycle could be repeated several times only leading to slight degradation 
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(Figure 14B). So as to determine the ratio of open and closed form at the 
photostationary state, DTE-phosphate 6 was analyzed by HPLC both before and after 
irradiation with 312 nm light for 30 s (Figure 14C). Since the isomers eluted at clearly 
different time points, the corresponding peak intensities could be used to determine 
the amount of closed isomer emerging upon irradiation. Remarkably, 97 % of com-
pound 6 were converted to the ring-closed form. Similar results were obtained for the 
other photoswitches, thus confirming the magnificent photoconversion yields of the 
DTE scaffold [170]. Taken together, the described photochemical features are perfectly 
in line with previously published data on DTE-based inhibitors [162]. 
Subsequently, the compounds were tested for the ability to inhibit the ProFAR 
isomerization activity of mtPriA, which was monitored spectrophotometrically at 
300 nm [44]. After ensuring the stability of all open and closed DTE-switches under 
assay conditions, steady-state kinetics were performed in the presence of different 
concentrations of each inhibitor candidate (saturation curves for compound 6 are 
shown in Figure S4, publication C). While the turnover number practically remained 
constant throughout all measurements, the   
 roFA  value consistently rose with increas-
ing amounts of the respective photoswitch (Table 2). Thus, each compound inhibited 
mtPriA in a competitive fashion, proving the efficiency of the design concept. Having 
determined the   
 roFA  value in the absence of inhibitor, the apparent   
 roFA  values 
could be used to calculate the inhibitory constants Ki with Formula S1, publication C 
(Table 2). All deduced Ki values are in the low micromolar range and hence compare 
well with or even surpass the Michaelis constant for the natural substrate ProFAR. 
Merely considering the distances of the phosphorous atoms, the open isomers of the 
meta-substituted compounds 6 and 12 come closest to the 16.9 Å observed for the 
mtPriA-PRFAR complex (PDB ID 3zs4 [60]; Scheme 2, publication C) and thus should 
exhibit the highest inhibitory potential. Indeed, their Ki values are as low as 0.55 µM 
and 1.6 µM, respectively. When testing the corresponding ring-closed isomers, the 
inhibition activities decreased threefold in case of meta-phosphonate 12 and even 
eightfold for meta-phosphate 6. In contrast, the open and closed isomer of ortho-
phosphate 5 affected mtPriA activity to a similar extent. Although the same result was 
found for para-phosphate 7, the introduction of a phosphonate moiety in para-position 
(compound 13) gave rise to a threefold difference in the Ki values of the open and 
closed form. 
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Table 2. Steady-state kinetic constants for the ProFAR isomerization activity of mtPriA in the 
absence and presence of compounds 5 - 7, 12, and 13 in their open/closed forms. 
Inhibitor c(I) [µM] kcat [s-1]   
 roFA  [µM] Ki [µM] 
 open/closed 
-  0.49 
0.49 
0.57 
8.6 
9.2 
8.1 
 
5 5.0/5.0 
10.5/10.5 
18.0/18.0 
0.47/0.58 
0.59/0.55 
0.55/0.60 
12.7/13.9 
20.9/21.5 
32.5/35.2 
10.5/8.1 
7.3/7.0 
6.5/5.8 
6 0.4/2.0 
0.6/3.5 
0.8/8.0 
0.52/0.56 
0.59/0.60 
0.55/0.61 
16.2/12.4 
18.7/15.9 
18.5/23.7 
0.45/4.5 
0.51/4.1 
0.69/4.6 
7 2.0/3.5 
3.5/7.0 
5.0/10.5 
0.47/0.58 
0.47/0.55 
0.47/0.53 
13.1/16.2 
17.7/24.8 
21.7/35.6 
3.8/4.0 
3.3/3.7 
3.3/3.3 
12 1.5/4.0 
2.5/10.0 
4.0/15.0 
0.57/0.55 
0.58/0.57 
0.60/0.55 
16.3/15.2 
22.3/27.1 
29.4/34.9 
1.7/5.2 
1.6/4.6 
1.7/4.9 
13 5.0/15.0 
10.0/15.0 
15.0/20.0 
0.60/0.58 
0.60/0.57 
0.59/0.57 
15.7/15.1 
20.7/15.0 
26.6/14.7 
6.1/19.8 
7.1/20.2 
7.2/28.2 
Three substrate saturation curves were recorded at different concentrations c(I) of each 
compound and form (open/closed). The deduced kcat and  
 roFA  values were used to calculate 
the respective inhibition constants with Formula S1, publication C. Taken from Table S1, 
publication C. 
According to the steady-state kinetics, the inhibitory strength of three out of five 
compounds depends on the photoisomeric state. When irradiated with UV light, the 
inhibition activity dropped in all three cases by up to eightfold. However, the activity 
of mtPriA was not directly targeted in these measurements, since the respective 
isomers had already been added before the reaction was initiated. Therefore, it had to 
be demonstrated that the enzymatic performance can also be controlled during 
catalysis. To this end, the isomerization of ProFAR was followed spectrophotomet-
rically in the presence of meta-phosphate 6 in its ring-open form (Figure 15). When the 
maximal velocity was reached after an initial lag phase, the solution was irradiated 
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with UV light to generate the ring-closed isomer of 6. As a consequence thereof, the 
reaction rate could be increased about threefold under the prevailing conditions. 
 
Figure 15. Remote control of mtPriA activity through ring-closure of compound 6. 
4 µM of meta-phosphate 6 in its open form were added to a typical setup of ProFAR isomeriza-
tion (5 µM ProFAR, 100 mM ammonium acetate, 0.18 μ  HisF, and 0.15 μ  mtPriA in 50 mM 
Tris/acetate pH 8.5 at 25 °C). The turnover of ProFAR was monitored spectrophotometrically at 
300 nm. After reaching its maximal velocity, the reaction mixture was either left unchanged 
(grey) or irradiated with 312 nm light for 10 s (black). The accompanying baseline shift, 
resulting from different absorptions of the open and closed isomer at 300 nm, was corrected by 
means of a reference solution without enzymes. Taken from Figure 2, publication C. 
Photoswitches like azobenzene and spiropyran significantly alter their overall 
geometry and polarity upon irradiation [151]. In contrast, ring-closure of the DTE 
scaffold only slightly affects the molecular length (Scheme 2, publication C), but mainly 
reduces the conformational flexibility [162]. Regarding the designed inhibitors, the 
open isomers possess four freely rotatable carbon-carbon bonds, which connect the 
thiophene heterocycles either with the central cyclopentene ring or with the terminal 
phenyl groups (Figure 13B). When irradiated with UV light, two flexible carbon-carbon 
bonds are incorporated in the newly formed cyclohexadiene ring. Furthermore, the 
closed isomers are completely conjugated, restricting the motility of the remaining 
non-cyclic carbon-carbon bonds. These conformational constraints probably hamper 
the adaptation to the active site of mtPriA and thus reduce the inhibition activities of 
the closed forms of compounds 6, 12, and 13, even if the binding of the closed isomers 
is entropically favored. Furthermore, the deviating flexibilities of para-substituted 
compounds 7 and 13 offer a possible explanation for their different light-controllable 
inhibition properties (Table 2). While ring-closure of para-phosphate 7 did not alter the 
inhibitory activity, the Ki value of para-phosphonate 13 reduced threefold upon UV 
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irradiation. Although both inhibitors exhibit comparable distances between their 
phosphorous atoms (Scheme 2, publication C), para-phosphonate 13 lacks the versatile 
oxygen bridges connecting the phenyl rings with the terminal anchor groups. Conse-
quently, the closed isomer of 13 is strongly impaired in its motility, giving rise to a 
distinct difference in the inhibition constants of the open and closed state.  
Finally, in order to get a more detailed insight into the light-induced changes of 
the binding mode, MD simulations were performed with the open and closed isomer 
of meta-phosphate 6 bound to mtPriA. As expected, given the low inhibitory constants, 
the termini of both forms are clearly fixed in the phosphate binding sites via several 
hydrogen bond interactions (Figure 16A and Figure 16B). However, the molecular
 
Figure 16. MD simulations of mtPriA with open and closed compound 6. 
A (open)/B (closed): Representative ribbon diagrams are shown with views on the active sites 
(hydrogen bond interactions of the phosphate groups are indicated by dashed lines). C (open)/ 
D (closed): For each isomer, three independent calculations were performed and the respective 
conformers with the best binding energies are superposed. PDB ID: 3zs4. Taken from Figure 3, 
publication C. 
cores of the inhibitors obviously vary. While the open isomer converges to widely 
coincident, twofold symmetric structures in three independent calculations (Figure 
16C), the geometries of the closed form deviate from each other (Figure 16D). Here, one 
terminal phenyl ring is twisted to compensate for the structural rigidity of the molecu-
lar core and to enable an appropriate coordination of the attached phosphate group. 
The accompanying distortion of the twofold rotational symmetry is clearly reflected in 
the determined binding energies which are consistently higher than the values 
obtained for the open isomer (Table S2, publication C). 
Recently, the design of light-inducible ion receptors and channels allowed for the 
spatiotemporal regulation of neuronal activity by irradiation [171, 172]. Targeting 
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neural systems is particularly effective, as even minor changes in the binding strength 
of the ligand trigger a nonlinear signal response and thus significantly affect the 
cellular output [173]. In contrast, light-control of enzymatic function is more preten-
tious and only few successful attempts have been reported [151]. Nevertheless, aiming 
at the metabolic branch-point enzyme mtPriA, the activity of DTE-based inhibitors 
could be reduced or enhanced by up to one order of magnitude through irradiation 
with UV and visible light, respectively. Remarkably, all photoisomers were nearly 
quantitatively formed and thermally stable, confirming the valuable photochemical 
features of the DTE scaffold [162]. By analogy with described two-pronged inhibitors 
[161, 162, 174, 175], the DTE compounds were equipped with two phosphate or 
phosphonate groups capable of docking at the phosphate binding sites of mtPriA. This 
dual anchoring strategy seems especially important for the effect of DTE switches, 
since the light-induced change in molecular flexibility only influences the inhibitory 
activity to a reasonable extent, if the mobility of the ligand is restricted by terminal 
fixation. Interestingly, other enzymes and pathways can theoretically be targeted with 
similar DTE switches, as phosphate is a widely distributed moiety among metabolites. 
Two phosphate binding sites are for instance found in pyridoxine-5’ phosphate 
synthase [176] and in certain aldolases [177, 178]. Hence, the presented design concept 
may be transferred to various enzymatic functions, enabling control of different 
cellular processes by light.  
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